about
Genetic associations in type I interferon related pathways with autoimmunityRecent findings on genetics of systemic autoimmune diseasesGenetic and physical interaction of the B-cell systemic lupus erythematosus-associated genes BANK1 and BLK.Genetic basis of Sjögren's syndrome. How strong is the evidence?Kallikrein genes are associated with lupus and glomerular basement membrane-specific antibody-induced nephritis in mice and humans.Replication of the TNFSF4 (OX40L) promoter region association with systemic lupus erythematosusFine mapping and conditional analysis identify a new mutation in the autoimmunity susceptibility gene BLK that leads to reduced half-life of the BLK protein.Meta-analysis of HLA-DRB1 polymorphism in Latin American patients with rheumatoid arthritis.PXK locus in systemic lupus erythematosus: fine mapping and functional analysis reveals novel susceptibility gene ABHD6.Bcl-2 antagonist killer 1 (BAK1) polymorphisms influence the risk of developing autoimmune rheumatic diseases in women.A 3'-untranslated region variant is associated with impaired expression of CD226 in T and natural killer T cells and is associated with susceptibility to systemic lupus erythematosus.Association ofSTAT4with rheumatoid arthritis: A replication study in three European populationsPromoter Insertion/Deletion in the IRF5 Gene Is Highly Associated with Susceptibility to Systemic Lupus Erythematosus in Distinct Populations, But Exerts a Modest Effect on Gene Expression in Peripheral Blood Mononuclear CellsDetecting Epistasis with Restricted Response Patterns in Pairs of Biallelic LociIRF5 is associated with primary antiphospholipid syndrome, but is not a major risk factorAssociation ofSTAT4andBLK, but notBANK1orIRF5, with primary antiphospholipid syndrome
P50
Q34350182-D6A0BE6D-056F-4D21-8249-9738CA729C77Q34384322-75483B30-9CF1-4598-9219-14408D03E956Q35711787-A1D138D7-0C2E-4A33-95DB-2C4980851143Q36502292-C672256B-22E8-4705-9EEB-D501D3285A33Q37143371-FF207333-B4CB-4A6E-9C2F-2E5A7209146EQ37402475-73A5F0E7-8363-430D-9702-5F5BB31BC200Q42099090-C844C9A2-1E36-4298-A775-539B310BC230Q42622247-CF1696C5-6199-49C6-A8D3-E2E8E428DB95Q46023783-807F84FD-5617-46FC-A41E-F9494B525BABQ51771654-CE4CFA81-73F3-4514-838A-F7F901988B54Q54417738-1C59150B-1B79-410C-A89D-764E44C47C77Q56968794-C8171AAF-C86D-4123-BA3C-0BEB0C47606CQ57307084-2A1DCC3D-66B6-4BA2-9420-0E23CC613A86Q57461721-08BB84F6-9173-4B2B-A757-78A8FEBBA12EQ57461748-0749BCE9-E219-4D89-BBB7-3ECC9C7FFD3EQ57461793-D8338A00-29CB-4C8C-AA91-1A3ECAE24962
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Angélica M Delgado-Vega
@ast
Angélica M Delgado-Vega
@en
Angélica M Delgado-Vega
@es
Angélica M Delgado-Vega
@nl
type
label
Angélica M Delgado-Vega
@ast
Angélica M Delgado-Vega
@en
Angélica M Delgado-Vega
@es
Angélica M Delgado-Vega
@nl
prefLabel
Angélica M Delgado-Vega
@ast
Angélica M Delgado-Vega
@en
Angélica M Delgado-Vega
@es
Angélica M Delgado-Vega
@nl
P106
P31
P496
0000-0002-9865-0591